Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04010097
Other study ID # 87RI19_0009
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 30, 2019
Est. completion date January 1, 2022

Study information

Verified date November 2021
Source University Hospital, Limoges
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is hypothesized that chewing-gums may be a useful test to unmask jaws intermittent claudication in order to enhance the diagnosis of Giant Cell Arteritis (GCA).


Description:

GCA is the most common vasculitis. The diagnosis easily could be made in patients over 50 years old with headache, inflammatory belt pain, claudication of the jaws, scalp hyperesthesia, ophthalmological manifestations and an inflammatory syndrome. However, the clinical pictures could be less suggestive, hence diagnostic difficulties. Some patients have only isolated inflammatory syndrome. To confirm the diagnosis, sometimes PET CT or temporal artery biopsy is used, but access to a PET CT is sometimes complex, biopsy of temporal arteries is only positive in about 70% cases. Early diagnosis is important, however, to avoid irreversible complications, especially ophthalmological complications. One in six patients has definitive amaurosis, because of diagnosis delay. The current diagnostic delay is estimated on average at 9 weeks. Jaw intermittent claudication probably has a very good positive predictive value and this clinical sign often carries conviction. Patients with claudication of the jaws also have a greater visual risk. Kuo reports two observations of patients with claudication of the jaws revealed by the "chewing gum test" after 2 minutes of chewing. It is therefore proposed to perform a chewing gum test to assess the sensitivity and specificity of this test, compared to the interview. Once the test is done, the study is completed for the patient.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 66
Est. completion date January 1, 2022
Est. primary completion date January 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Group 1 - Any patient suspected of having GCA, that is to say in practice patients in whom a doctor plans a Doppler ultrasound of temporal arteries or a temporal arteritis biopsy or an imagery (Angio-CT, Angio-MRI, PET- to scan - Patient over 50 years old - Patient able to chew a chewing gum for 4 minutes Group 2 - Patients free from GCA - Age matched (± 3 years) - Patient able to chew a chewing gum for 4 minutes Exclusion Criteria: - Group 1 - Patients known to have a temporomandibular joint pathology - Patients who started corticosteroid therapy Group 2 - Patients known to have temporomandibular joint pathology - Patients who started corticosteroid therapy

Study Design


Intervention

Other:
chewing gum
The test involves chewing a chewing gum for 4 minutes

Locations

Country Name City State
France CH Avignon Avignon
France CHU Limoges Limoges
France CHU de Nantes Nantes
France CH St Antoine Paris
France CHU Tours Tours
France CH Valenciennes Valenciennes

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the sensitivity and specificity of the chewing gum test in Horton's disease. Determination of:
True positive: Sick people correctly identified as sick False positive: Healthy people incorrectly identified as sick True negative: Healthy people correctly identified as healthy False negative: Sick people incorrectly identified as healthy
Then wa calculate:
the number true positives TP the number of false positives FP the number of true negatives TN the number of false negatives.FN
Specificty= TN/(TN+FP) Sensitivity= : TP/(TP+FN) The test is performed twice an hour apart, to verify its reproducibility, before the introduction of corticosteroid therapy, with chewing gums without sugar.
Day 1
Secondary Evaluate the positive predictive value, the negative predictive value, and the likelihood ratio of the chewing gum test in Horton's disease, predictive value= TP/(TP+FP) Day1
See also
  Status Clinical Trial Phase
Completed NCT03360162 - Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler
Recruiting NCT03313102 - Study of T Lymphocytes in Patients With Horton Disease N/A
Not yet recruiting NCT06244069 - Clonal Hematopoiesis in Giant Cell Arteritis
Completed NCT04142515 - Collection and Analysis of the Clinical and Biological Characteristics of Patients Treated for Giant Cells ARTEitis (Horton's Disease)
Terminated NCT02473029 - Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease